The influence of treatment-emergent adverse reactions on selecting phosphodiesterase type 5 inhibitors

Authors
Category Primary study
JournalKorean Journal of Urology
Year 2006
This article has no abstract
Epistemonikos ID: fd9a1220dd38894f3d2691d9817d25780182b23d
First added on: Jul 07, 2015